Mercury in Drug and Biologic Products
The information in this list is derived from submissions made by manufacturers+ in response to the agency’s call-for-data notices of December 14, 1998 (63 FR 68775), April 29, 1999 (64 FR 23083) and February 3, 2003 (68 FR 5299), the agency’s Drug Registration and Listing System, and other agency sources.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed